Literature DB >> 23917993

Validation of the Brazilian version of the musculoskeletal tumor society rating scale for lower extremity bone sarcoma.

Daniel Cesar Seguel Rebolledo1, João Ricardo Nickenig Vissoci, Ricardo Pietrobon, Olavo Pires de Camargo, Andre Mathias Baptista.   

Abstract

BACKGROUND: The Musculoskeletal Tumor Society (MSTS) rating scale is an English-language instrument used worldwide to assess functional evaluation of patients with musculoskeletal cancer. Despite its use in several studies in English-speaking countries, its validity for assessing patients in other languages is unknown. The translation and validation of widely used scales can facilitate the comparison across international patient samples. OBJECTIVES/PURPOSES: The objectives of this study were (1) to translate and culturally adapt the MSTS rating scale for functional evaluation in patients with lower extremity bone sarcomas to Brazilian Portuguese; (2) analyze its factor structure; and (3) test the reliability and (4) validity of this instrument.
METHOD: The MSTS rating scale for lower limbs was translated from English into Brazilian Portuguese. Translations were synthesized, translated back into English, and reviewed by a multidisciplinary committee for further implementation. The questionnaire was administered to 67 patients treated for malignant lower extremity bone tumors who were submitted to limb salvage surgery or amputation. They also completed a Brazilian version of the Toronto Extremity Salvage Score (TESS). Psychometric properties were analyzed including factor structure analysis, internal consistency, interobserver reliability, test-retest reliability, and construct validity (by comparing the adapted MSTS with TESS and discriminant validity).
RESULTS: The MSTS rating scale for lower limbs was translated and culturally adapted to Brazilian Portuguese. The MSTS-BR proved to be adequate with only one latent dimension. The scale was also found to be reliable in a population that speaks Brazilian Portuguese showing good internal consistency (Cronbach's alpha = 0.84) and reliability (test-retest reliability and interobserver agreement of 0.92 and 0.98, respectively). Validity of the Brazilian MSTS rating scale was proved by moderate with TESS and good discriminant validity.
CONCLUSIONS: The Brazilian version of the MSTS rating scale was translated and validated. It is a reliable tool to assess functional outcome in patients with lower extremity bone sarcomas. It can be used for functional evaluation of Brazilian patients and crosscultural comparisons.

Entities:  

Mesh:

Year:  2013        PMID: 23917993      PMCID: PMC3825918          DOI: 10.1007/s11999-013-3211-4

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  15 in total

Review 1.  Guidelines for the process of cross-cultural adaptation of self-report measures.

Authors:  D E Beaton; C Bombardier; F Guillemin; M B Ferraz
Journal:  Spine (Phila Pa 1976)       Date:  2000-12-15       Impact factor: 3.468

2.  Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations.

Authors:  N K Aaronson; M Muller; P D Cohen; M L Essink-Bot; M Fekkes; R Sanderman; M A Sprangers; A te Velde; E Verrips
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

3.  Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur.

Authors:  M A Simon; M A Aschliman; N Thomas; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1986-12       Impact factor: 5.284

4.  Function and health status in surgically treated bone metastases.

Authors:  Max Talbot; Robert E Turcotte; Marc Isler; Danièle Normandin; David Iannuzzi; Phillip Downer
Journal:  Clin Orthop Relat Res       Date:  2005-09       Impact factor: 4.176

5.  Cross-cultural adaptation and validation of the Brazilian Portuguese version of the short musculoskeletal function assessment questionnaire: the SMFA-BR.

Authors:  Marcus K Taylor; Ricardo Pietrobon; Andreia Menezes; Steven A Olson; Deng Pan; Neeti Bathia; Robert F DeVellis; Paulo Kume; Laurence D Higgins
Journal:  J Bone Joint Surg Am       Date:  2005-04       Impact factor: 5.284

6.  Internal and external hemipelvectomy or flail hip in patients with sarcomas: quality-of-life and functional outcomes.

Authors:  Michael J Griesser; Blake Gillette; Martha Crist; Xueliang Pan; Peter Muscarella; Thomas Scharschmidt; Joel Mayerson
Journal:  Am J Phys Med Rehabil       Date:  2012-01       Impact factor: 2.159

7.  Development of a measure of physical function for patients with bone and soft tissue sarcoma.

Authors:  A M Davis; J G Wright; J I Williams; C Bombardier; A Griffin; R S Bell
Journal:  Qual Life Res       Date:  1996-10       Impact factor: 4.147

8.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups.

Authors:  C A McHorney; J E Ware; J F Lu; C D Sherbourne
Journal:  Med Care       Date:  1994-01       Impact factor: 2.983

9.  A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.

Authors:  W F Enneking; W Dunham; M C Gebhardt; M Malawar; D J Pritchard
Journal:  Clin Orthop Relat Res       Date:  1993-01       Impact factor: 4.176

10.  The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).

Authors:  Michael Alexander; William Berger; Patricia Buchholz; John Walt; Caroline Burk; Jeff Lee; Rob Arbuckle; Linda Abetz
Journal:  Health Qual Life Outcomes       Date:  2005-10-31       Impact factor: 3.186

View more
  8 in total

1.  Reliability and Validity of a Japanese-language and Culturally Adapted Version of the Musculoskeletal Tumor Society Scoring System for the Lower Extremity.

Authors:  Shintaro Iwata; Kosuke Uehara; Koichi Ogura; Toru Akiyama; Yusuke Shinoda; Tsukasa Yonemoto; Akira Kawai
Journal:  Clin Orthop Relat Res       Date:  2016-05-11       Impact factor: 4.176

2.  Editorial: Importance of Validating the Scores We Use to Assess Patients with Musculoskeletal Tumors.

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

3.  Reconstruction After Hemipelvectomy With the Ice-Cream Cone Prosthesis: What Are the Short-term Clinical Results?

Authors:  Irene Barrientos-Ruiz; Eduardo José Ortiz-Cruz; Manuel Peleteiro-Pensado
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

4.  The Discrepancy between Patient and Clinician Reported Function in Extremity Bone Metastases.

Authors:  Stein J Janssen; Eva A J van Rein; Nuno Rui Paulino Pereira; Kevin A Raskin; Marco L Ferrone; Francis J Hornicek; Santiago A Lozano-Calderon; Joseph H Schwab
Journal:  Sarcoma       Date:  2016-09-20

5.  Cross-cultural adaptation and validation of the Chinese version of Toronto Extremity Salvage Score for patients with extremity sarcoma.

Authors:  Leilei Xu; Minghui Sun; Weixiang Sun; Xiaodong Qin; Zezhang Zhu; Shoufeng Wang
Journal:  Springerplus       Date:  2016-07-19

6.  Functional evaluation for patients with lower extremity sarcoma: application of the Chinese version of Musculoskeletal Tumor Society scoring system.

Authors:  Leilei Xu; Xinhua Li; Zhou Wang; Jin Xiong; Shoufeng Wang
Journal:  Health Qual Life Outcomes       Date:  2017-05-19       Impact factor: 3.186

7.  Cross-cultural adaptation and validation of the Musculoskeletal Tumor Society (MSTS) scoring system and Toronto Extremity Salvage Score (TESS) for musculoskeletal sarcoma patients in Greece.

Authors:  Ioanna K Bolia; Olga D Savvidou; Hyunwoo P Kang; Nikolaos Chatzichristodoulou; Panayiotis D Megaloikonomos; Evanthia Mitsiokapa; Andreas F Mavrogenis; Panayiotis J Papagelopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-03-15

8.  Validation of the Danish version of the musculoskeletal tumour society score questionnaire.

Authors:  Casper Kloster Pingel Saebye; Johnny Keller; Thomas Baad-Hansen
Journal:  World J Orthop       Date:  2019-01-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.